Betoptic

Glaucoma, Hypertensive disease, Ocular Hypertension + 2 more
Treatment
1 FDA approval
20 Active Studies for Betoptic

What is Betoptic

BetaxololThe Generic name of this drug
Treatment SummaryA medication that blocks the activity of a certain type of hormone in the heart, without providing any additional effects.
Kerloneis the brand name
image of different drug pills on a surface
Betoptic Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Kerlone
Betaxolol
1989
19

Approved as Treatment by the FDA

Betaxolol, also known as Kerlone, is approved by the FDA for 1 uses such as Hypertensive disease .
Hypertensive disease
Helps manage High Blood Pressure (Hypertension)

Effectiveness

How Betoptic Affects PatientsBetaxolol is a drug that blocks certain receptors in the heart, which reduces the heart rate and blood pressure. It is used to treat high blood pressure, heart arrhythmias, coronary heart disease, glaucoma, and to prevent non-fatal cardiac events in patients with heart failure. Betaxolol also stops the release of a hormone made by the kidneys that causes blood vessels to constrict. It is a type of fat-soluble drug and does not stimulate the heart or stabilize cell membranes.
How Betoptic works in the bodyBetaxolol works by blocking the effects of certain hormones that speed up your heart rate and widen your blood vessels. This helps to lower your heart rate, blood pressure, and may cause a drop in blood pressure when you stand up. It can also block hormones in your bronchial muscles, which can lead to narrowing of the airways.

When to interrupt dosage

The measure of Betoptic is contingent upon the diagnosed condition, including Glaucoma, Open-Angle, Increased Intra Ocular Pressure (IOP) and Betoptic. The extent of dosage is subject to the technique of administration (e.g. Kit or Tablet, coated) featured in the table beneath.
Condition
Dosage
Administration
Glaucoma
, 10.0 mg, 20.0 mg, 5.0 mg/mL, 5.6 mg/mL, 0.5 %, 0.25 %, 2.8 mg/mL, 2.5 mg/mL
, Oral, Tablet, coated, Tablet, coated - Oral, Ophthalmic, Solution / drops - Ophthalmic, Solution / drops, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Ophthalmic, Suspension, Suspension - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Kit, Kit - Ophthalmic, Solution - Ophthalmic, Solution
Hypertensive disease
, 10.0 mg, 20.0 mg, 5.0 mg/mL, 5.6 mg/mL, 0.5 %, 0.25 %, 2.8 mg/mL, 2.5 mg/mL
, Oral, Tablet, coated, Tablet, coated - Oral, Ophthalmic, Solution / drops - Ophthalmic, Solution / drops, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Ophthalmic, Suspension, Suspension - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Kit, Kit - Ophthalmic, Solution - Ophthalmic, Solution
Ocular Hypertension
, 10.0 mg, 20.0 mg, 5.0 mg/mL, 5.6 mg/mL, 0.5 %, 0.25 %, 2.8 mg/mL, 2.5 mg/mL
, Oral, Tablet, coated, Tablet, coated - Oral, Ophthalmic, Solution / drops - Ophthalmic, Solution / drops, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Ophthalmic, Suspension, Suspension - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Kit, Kit - Ophthalmic, Solution - Ophthalmic, Solution
Glaucoma, Open-Angle
, 10.0 mg, 20.0 mg, 5.0 mg/mL, 5.6 mg/mL, 0.5 %, 0.25 %, 2.8 mg/mL, 2.5 mg/mL
, Oral, Tablet, coated, Tablet, coated - Oral, Ophthalmic, Solution / drops - Ophthalmic, Solution / drops, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Ophthalmic, Suspension, Suspension - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Kit, Kit - Ophthalmic, Solution - Ophthalmic, Solution
Betoptic
, 10.0 mg, 20.0 mg, 5.0 mg/mL, 5.6 mg/mL, 0.5 %, 0.25 %, 2.8 mg/mL, 2.5 mg/mL
, Oral, Tablet, coated, Tablet, coated - Oral, Ophthalmic, Solution / drops - Ophthalmic, Solution / drops, Tablet, film coated, Tablet, film coated - Oral, Liquid, Liquid - Ophthalmic, Suspension, Suspension - Ophthalmic, Suspension / drops - Ophthalmic, Suspension / drops, Kit, Kit - Ophthalmic, Solution - Ophthalmic, Solution

Warnings

There are 20 known major drug interactions with Betoptic.
Common Betoptic Drug Interactions
Drug Name
Risk Level
Description
4-Bromo-2,5-dimethoxyphenethylamine
Major
The therapeutic efficacy of 4-Bromo-2,5-dimethoxyphenethylamine can be decreased when used in combination with Betaxolol.
4-Methoxyamphetamine
Major
The therapeutic efficacy of 4-Methoxyamphetamine can be decreased when used in combination with Betaxolol.
Abediterol
Major
The therapeutic efficacy of Abediterol can be decreased when used in combination with Betaxolol.
Adrafinil
Major
The therapeutic efficacy of Adrafinil can be decreased when used in combination with Betaxolol.
Agrostis gigantea pollen
Major
The risk of a hypersensitivity reaction to Agrostis gigantea pollen is increased when it is combined with Betaxolol.
Betoptic Toxicity & Overdose RiskThe lethal dose of betaxolol in mice is 350 to 400 mg/kg and 860 to 980 mg/kg in rats. Overdosing on this drug may result in slow heart rate, heart failure, low blood pressure, difficulty breathing, and low blood sugar.
image of a doctor in a lab doing drug, clinical research

Betoptic Novel Uses: Which Conditions Have a Clinical Trial Featuring Betoptic?

49 active research projects are in progress to assess the potential of Betoptic to reduce Increased Intra Ocular Pressure (IOP), Betoptic and Hypertensive ailments.
Condition
Clinical Trials
Trial Phases
Ocular Hypertension
10 Actively Recruiting
Phase 3, Phase 1, Phase 2, Not Applicable, Phase 4
Glaucoma
0 Actively Recruiting
Glaucoma, Open-Angle
34 Actively Recruiting
Not Applicable, Phase 3, Phase 4, Phase 1, Phase 2
Betoptic
0 Actively Recruiting
Hypertensive disease
28 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 3

Patient Q&A Section about betoptic

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Betoptic used for?

"The drug Betoptic is typically used to lower intraocular pressure in patients suffering from ocular hypertension or chronic open angle glaucoma. The recommended dosage is one drop in the affected eye(s), twice per day. Betoptic is not recommended for use in children."

Answered by AI

What is the difference between Betoptic and Betoptic s?

"Betoptic Eye Drops 0.5% and Betoptic S Eye Drops 0.25% can be used to reduce high intraocular pressure, as well as normal intraocular pressure, even if the patient does not have glaucoma."

Answered by AI

What drug class is Betoptic?

"Betaxolol decreases the amount of fluid produced by the eye. It is classified as a beta blocker."

Answered by AI

What is the generic name for Betoptic?

"Betaxolol, the generic version of Betoptic S, may be significantly cheaper compared to the brand version."

Answered by AI

Clinical Trials for Betoptic

Image of U Health in Miami, United States.

Cuffless PPG Monitor for High Blood Pressure

18+
All Sexes
Miami, FL
This study aims to validate the accuracy and reliability of blood pressure (BP) estimates obtained over 24 hours using a PPG-based chest-patch device compared to the gold standard ambulatory blood pressure monitoring (ABPM) method using an upper arm cuff-based oscillometric BP device, in both hypertensive and normotensive individuals referred by their provider to undergo a 24-hours ABPM for clinical indication. The Awake/Asleep test, which is the primary test recommended for automated wearable cuffless BP devices that are cuff-calibrated (based on the 2023 European Society of Hypertension (ESH) recommendations for the validation of cuffless blood pressure measuring devices), will be conducted in this study. The secondary aim of the study is to assess the feasibility and convenience of the PPG-based device.
Waitlist Available
Has No Placebo
U Health (+1 Sites)Ziad Zoghby, M.D., M.B.A.Biobeat Technologies Ltd.
Have you considered Betoptic clinical trials? We made a collection of clinical trials featuring Betoptic, we think they might fit your search criteria.Go to Trials
Image of Select Eye Care in Elkridge, United States.

Direct Selective Laser Trabeculoplasty for Glaucoma

18+
All Sexes
Elkridge, MD
The goal of this clinical trial is to to evaluate how well Direct Selective Laser Trabeculoplasty (DSLT) lowers eye pressure in eyes of adult, non-Caucasian participants with primary open angle glaucoma. The main question it aims to answer is: What is the washed out eye pressure (eye pressure when not on any glaucoma medications) of participants 6 months after the Direct Selective Laser Trabeculoplasty (DSLT) procedure compared to the washed out eye pressure of participants prior to the DSLT procedure. Participants will: Undergo the DSLT procedure in one or both eyes and visit the clinic 1 month, 3 months, and 6 months after the procedure to have their vision and eye pressure measured.
Recruiting
Has No Placebo
Select Eye CareSelect Eye Care
Have you considered Betoptic clinical trials? We made a collection of clinical trials featuring Betoptic, we think they might fit your search criteria.Go to Trials
Image of University of Alabama at Birmingham in Birmingham, United States.

Dietary Interventions for Hypertension

18+
All Sexes
Birmingham, AL
Natriuretic peptides (NPs) are hormones produced by the heart and play an important role in maintaining cardiovascular health and have favorable metabolic benefits. Low NP levels are associated with an increased likelihood of the development of cardiometabolic diseases like diabetes and hypertension. NP levels are known to be highly heritable, with up to half of the differences in NP levels being explained by genetics. The investigators aim to describe the genetic architecture of NPs by examining the genetic variants associated with NPs, and generate and validate a polygenic score (PGS) for NPs. The investigators will use this NP PGS to examine the association of genetically determined NP levels with cardiometabolic and cardiovascular outcomes. The investigators will conduct a genotype-guided physiological clinical trial that aims to assess the genetic factors affecting NP levels and their impact on blood pressure and NP response to saline infusion, high-salt diet, and low-salt diet. These findings will help support personal medicine approaches to lower the increasing burden of hypertension in the United States.
Waitlist Available
Has No Placebo
University of Alabama at BirminghamPankaj Arora, MD, FAHA
Have you considered Betoptic clinical trials? We made a collection of clinical trials featuring Betoptic, we think they might fit your search criteria.Go to Trials